← Browse by Condition
Medical Condition
hypovolemic shock
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3, Phase 4
ClinicalMetric tracks all active clinical trials for hypovolemic shock sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3 1
Phase 4 1
Top Sponsors
1 trial
1 trial
NCT05931601 Phase 3
Recruiting
Early Initiated Vasopressor Therapy in the Emergency Department
Enrollment
320 pts
Location
Denmark, Sweden
Sponsor
Odense University Hospital
NCT05956418 Phase 4
Recruiting
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
Enrollment
400 pts
Location
India
Sponsor
Pharmazz, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology